South Korea Neurology Devices Market Report by Type of Device (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices, Neurostimulation Devices, and Others), and Region 2026-2034
South Korea neurology devices market size reached USD 259.7 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 564.0 Million by 2034, exhibiting a growth rate (CAGR) of 9.00% during 2026-2034 . The increasing availability of advanced diagnostic and therapeutic equipment is propelling the market growth.
SOUTH KOREA NEUROLOGY DEVICES MARKET ANALYSIS:
Growing Demand for Advanced Medical Technologies
The surge in technological advancements in neurology, including AI-based imaging systems, reflects a heightened need for advanced medical diagnostic tools. This trend signifies a push towards integrating cutting-edge technologies to improve neurological disorder detection and treatment efficacy. As the focus intensifies on enhancing the capabilities of neurology tools, the market responds to the growing need for diagnostic and therapeutic solutions. For example, in March 2024, Philips and SyntheticMR introduced an AI-based quantitative brain imaging system in South Korea, integrating SmartSpeed, 3D SyntAc, and SyMRI NEURO technologies. This advanced tool enhances the diagnosis of neurological disorders, including multiple sclerosis and traumatic brain injuries, by analyzing brain tissues more precisely. This is the increasing the South Korea neurology devices market demand.
Increased Focus on Personalized Healthcare Solutions
Specialized treatments for individual patient needs, such as deep brain stimulation systems, demonstrate a shift towards more customized care approaches. Emphasizing personalized solutions aims to enhance treatment outcomes by addressing unique patient profiles and evolving medical conditions. For instance, in January 2024, Medtronic's FDA-approved Percept RC Deep Brain Stimulation system introduced BrainSense technology, enhancing the personalization of treatments for movement disorders and epilepsy. According to South Korea neurology devices market analysis report, this breakthrough positively impacted patient care options.
Expansion of Healthcare Infrastructure and Innovations
The strategic growth in healthcare infrastructure, coupled with new drug approvals and distribution agreements, signifies a commitment to enhancing treatment options. This expansion supports the development and accessibility of innovative therapies, thereby improving overall patient care and healthcare delivery. It is contributing to the South Korea neurology devices market share. They facilitate a broader range of solutions and improve patient outcomes, as these advancements drive greater market involvement. For example, in April 2024, Nxera Pharma announced an exclusive distribution agreement with Handok for PIVLAZ in South Korea. This drug, the first approved for preventing cerebral vasospasm after aneurysmal subarachnoid hemorrhage, will be available in early 2025, enhancing treatment options for neurological patients.
SOUTH KOREA NEUROLOGY DEVICES INDUSTRY SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the South Korea neurology devices market forecast at the country and regional levels for 2026-2034. Our report has categorized the market based on the type of device.
Breakup by Type of Device:
Cerebrospinal fluid (CSF) management devices are vital for conditions like hydrocephalus. Interventional neurology devices are generally used in neurovascular and stroke management procedures. Neurosurgery is critical in tumor removal processes. Neurostimulation devices are employed for treating movement disorders like Parkinson’s disease. The escalating demand for minimally invasive procedures will continue to augment the South Korea neurology devices market in the coming years.
Breakup by Region:
According to the South Korea neurology devices market outlook report, the Seoul Capital Area benefits from advanced healthcare facilities. Moreover, Yeongnam is experiencing increased demand due to the rising neurological disorder cases and the expanding hospital capabilities. In addition, Honam is investing in healthcare infrastructure to enhance access to neurology devices and treatments. Meanwhile, Hoseo is focusing on modernizing its medical facilities to support neurology services, whereas other regions are gradually adopting advanced technologies to improve neurological care, accessibility, and treatment outcomes.
COMPETITIVE LANDSCAPE:
The South Korea neurology devices market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis, such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant, has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea neurology devices market performed so far, and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea neurology devices market growth?
What is the breakup of the South Korea neurology devices market on the basis of type of device?
What are the various stages in the value chain of the South Korea neurology devices market?
What are the key driving factors and challenges in the South Korea neurology devices?
What is the structure of the South Korea neurology devices market, and who are the key players?
What is the degree of competition in the South Korea neurology devices market?
SOUTH KOREA NEUROLOGY DEVICES MARKET ANALYSIS:
- Major Market Drivers: The rising investments in research capabilities, healthcare infrastructures, and public health awareness are stimulating the market.
- Key Market Trends: The extensive healthcare investments in South Korea, aimed at improving neurological care and infrastructure, contribute significantly to the growing adoption of innovative neurology devices, thereby accelerating the market growth.
- Competitive Landscape: The report has provided a comprehensive analysis of the competitive landscape in the market. Also, detailed profiles of all major companies have been provided.
- Geographical Trends: Seoul Capital Area leads in neurology device adoption due to its advanced medical infrastructure. Moreover, Yeongnam experiences growth driven by the rising number of Parkinson’s cases. In contrast, Honam shows increased adoption with improving healthcare investments. Hoseo and other regions are expanding their market presence as regional healthcare infrastructure develops.
- Challenges and Opportunities: The high cost of advanced technologies and equipment can restrict access and adoption, which is hindering the market. However, increased government subsidies, financial incentives for healthcare providers, and collaborations with local manufacturers to reduce costs and improve accessibility will continue to bolster the market growth.
Growing Demand for Advanced Medical Technologies
The surge in technological advancements in neurology, including AI-based imaging systems, reflects a heightened need for advanced medical diagnostic tools. This trend signifies a push towards integrating cutting-edge technologies to improve neurological disorder detection and treatment efficacy. As the focus intensifies on enhancing the capabilities of neurology tools, the market responds to the growing need for diagnostic and therapeutic solutions. For example, in March 2024, Philips and SyntheticMR introduced an AI-based quantitative brain imaging system in South Korea, integrating SmartSpeed, 3D SyntAc, and SyMRI NEURO technologies. This advanced tool enhances the diagnosis of neurological disorders, including multiple sclerosis and traumatic brain injuries, by analyzing brain tissues more precisely. This is the increasing the South Korea neurology devices market demand.
Increased Focus on Personalized Healthcare Solutions
Specialized treatments for individual patient needs, such as deep brain stimulation systems, demonstrate a shift towards more customized care approaches. Emphasizing personalized solutions aims to enhance treatment outcomes by addressing unique patient profiles and evolving medical conditions. For instance, in January 2024, Medtronic's FDA-approved Percept RC Deep Brain Stimulation system introduced BrainSense technology, enhancing the personalization of treatments for movement disorders and epilepsy. According to South Korea neurology devices market analysis report, this breakthrough positively impacted patient care options.
Expansion of Healthcare Infrastructure and Innovations
The strategic growth in healthcare infrastructure, coupled with new drug approvals and distribution agreements, signifies a commitment to enhancing treatment options. This expansion supports the development and accessibility of innovative therapies, thereby improving overall patient care and healthcare delivery. It is contributing to the South Korea neurology devices market share. They facilitate a broader range of solutions and improve patient outcomes, as these advancements drive greater market involvement. For example, in April 2024, Nxera Pharma announced an exclusive distribution agreement with Handok for PIVLAZ in South Korea. This drug, the first approved for preventing cerebral vasospasm after aneurysmal subarachnoid hemorrhage, will be available in early 2025, enhancing treatment options for neurological patients.
SOUTH KOREA NEUROLOGY DEVICES INDUSTRY SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with the South Korea neurology devices market forecast at the country and regional levels for 2026-2034. Our report has categorized the market based on the type of device.
Breakup by Type of Device:
- Cerebrospinal Fluid Management Devices
- Interventional Neurology Devices
- Interventional/Surgical Simulators
- Neurothrombectomy Devices
- Carotid Artery Stents
- Embolic Coils
- Support Devices
- Neurosurgery Devices
- Neuroendoscopes
- Stereotactic Systems
- Aneurysm Clips
- Others
- Neurostimulation Devices
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Others
Cerebrospinal fluid (CSF) management devices are vital for conditions like hydrocephalus. Interventional neurology devices are generally used in neurovascular and stroke management procedures. Neurosurgery is critical in tumor removal processes. Neurostimulation devices are employed for treating movement disorders like Parkinson’s disease. The escalating demand for minimally invasive procedures will continue to augment the South Korea neurology devices market in the coming years.
Breakup by Region:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
According to the South Korea neurology devices market outlook report, the Seoul Capital Area benefits from advanced healthcare facilities. Moreover, Yeongnam is experiencing increased demand due to the rising neurological disorder cases and the expanding hospital capabilities. In addition, Honam is investing in healthcare infrastructure to enhance access to neurology devices and treatments. Meanwhile, Hoseo is focusing on modernizing its medical facilities to support neurology services, whereas other regions are gradually adopting advanced technologies to improve neurological care, accessibility, and treatment outcomes.
COMPETITIVE LANDSCAPE:
The South Korea neurology devices market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis, such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant, has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea neurology devices market performed so far, and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea neurology devices market growth?
What is the breakup of the South Korea neurology devices market on the basis of type of device?
What are the various stages in the value chain of the South Korea neurology devices market?
What are the key driving factors and challenges in the South Korea neurology devices?
What is the structure of the South Korea neurology devices market, and who are the key players?
What is the degree of competition in the South Korea neurology devices market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA NEUROLOGY DEVICES MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA NEUROLOGY DEVICES MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA NEUROLOGY DEVICES MARKET - BREAKUP BY TYPE OF DEVICE
6.1 Cerebrospinal Fluid Management Devices
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Interventional Neurology Devices
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Segmentation
6.2.3.1 Interventional/Surgical Simulators
6.2.3.2 Neurothrombectomy Devices
6.2.3.3 Carotid Artery Stents
6.2.3.4 Embolic Coils
6.2.3.5 Support Devices
6.2.4 Market Forecast (2026-2034)
6.3 Neurosurgery Devices
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Segmentation
6.3.3.1 Neuroendoscopes
6.3.3.2 Stereotactic Systems
6.3.3.3 Aneurysm Clips
6.3.3.4 Others
6.3.4 Market Forecast (2026-2034)
6.4 Neurostimulation Devices
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Segmentation
6.4.3.1 Spinal Cord Stimulation Devices
6.4.3.2 Deep Brain Stimulation Devices
6.4.3.3 Sacral Nerve Stimulation Devices
6.4.3.4 Others
6.4.4 Market Forecast (2026-2034)
6.5 Others
6.5.1 Historical and Current Market Trends (2020-2025)
6.5.2 Market Forecast (2026-2034)
7 SOUTH KOREA NEUROLOGY DEVICES MARKET – BREAKUP BY REGION
7.1 Seoul Capital Area
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Breakup by Type of Device
7.1.4 Key Players
7.1.5 Market Forecast (2026-2034)
7.2 Yeongnam (Southeastern Region)
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Breakup by Type of Device
7.2.4 Key Players
7.2.5 Market Forecast (2026-2034)
7.3 Honam (Southwestern Region)
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Breakup by Type of Device
7.3.4 Key Players
7.3.5 Market Forecast (2026-2034)
7.4 Hoseo (Central Region)
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Breakup by Type of Device
7.4.4 Key Players
7.4.5 Market Forecast (2026-2034)
7.5 Others
7.5.1 Historical and Current Market Trends (2020-2025)
7.5.2 Market Forecast (2026-2034)
8 SOUTH KOREA NEUROLOGY DEVICES MARKET – COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant
9 PROFILES OF KEY PLAYERS
9.1 Company A
9.1.1 Business Overview
9.1.2 Product Portfolio
9.1.3 Business Strategies
9.1.4 SWOT Analysis
9.1.5 Major News and Events
9.2 Company B
9.2.1 Business Overview
9.2.2 Product Portfolio
9.2.3 Business Strategies
9.2.4 SWOT Analysis
9.2.5 Major News and Events
9.3 Company C
9.3.1 Business Overview
9.3.2 Product Portfolio
9.3.3 Business Strategies
9.3.4 SWOT Analysis
9.3.5 Major News and Events
9.4 Company D
9.4.1 Business Overview
9.4.2 Product Portfolio
9.4.3 Business Strategies
9.4.4 SWOT Analysis
9.4.5 Major News and Events
9.5 Company E
9.5.1 Business Overview
9.5.2 Product Portfolio
9.5.3 Business Strategies
9.5.4 SWOT Analysis
9.5.5 Major News and Events
10 SOUTH KOREA NEUROLOGY DEVICES MARKET - INDUSTRY ANALYSIS
10.1 Drivers, Restraints, and Opportunities
10.1.1 Overview
10.1.2 Drivers
10.1.3 Restraints
10.1.4 Opportunities
10.2 Porters Five Forces Analysis
10.2.1 Overview
10.2.2 Bargaining Power of Buyers
10.2.3 Bargaining Power of Suppliers
10.2.4 Degree of Competition
10.2.5 Threat of New Entrants
10.2.6 Threat of Substitutes
10.3 Value Chain Analysis
11 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA NEUROLOGY DEVICES MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA NEUROLOGY DEVICES MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA NEUROLOGY DEVICES MARKET - BREAKUP BY TYPE OF DEVICE
6.1 Cerebrospinal Fluid Management Devices
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Interventional Neurology Devices
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Segmentation
6.2.3.1 Interventional/Surgical Simulators
6.2.3.2 Neurothrombectomy Devices
6.2.3.3 Carotid Artery Stents
6.2.3.4 Embolic Coils
6.2.3.5 Support Devices
6.2.4 Market Forecast (2026-2034)
6.3 Neurosurgery Devices
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Segmentation
6.3.3.1 Neuroendoscopes
6.3.3.2 Stereotactic Systems
6.3.3.3 Aneurysm Clips
6.3.3.4 Others
6.3.4 Market Forecast (2026-2034)
6.4 Neurostimulation Devices
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2020-2025)
6.4.3 Market Segmentation
6.4.3.1 Spinal Cord Stimulation Devices
6.4.3.2 Deep Brain Stimulation Devices
6.4.3.3 Sacral Nerve Stimulation Devices
6.4.3.4 Others
6.4.4 Market Forecast (2026-2034)
6.5 Others
6.5.1 Historical and Current Market Trends (2020-2025)
6.5.2 Market Forecast (2026-2034)
7 SOUTH KOREA NEUROLOGY DEVICES MARKET – BREAKUP BY REGION
7.1 Seoul Capital Area
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Breakup by Type of Device
7.1.4 Key Players
7.1.5 Market Forecast (2026-2034)
7.2 Yeongnam (Southeastern Region)
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Breakup by Type of Device
7.2.4 Key Players
7.2.5 Market Forecast (2026-2034)
7.3 Honam (Southwestern Region)
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Breakup by Type of Device
7.3.4 Key Players
7.3.5 Market Forecast (2026-2034)
7.4 Hoseo (Central Region)
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2020-2025)
7.4.3 Market Breakup by Type of Device
7.4.4 Key Players
7.4.5 Market Forecast (2026-2034)
7.5 Others
7.5.1 Historical and Current Market Trends (2020-2025)
7.5.2 Market Forecast (2026-2034)
8 SOUTH KOREA NEUROLOGY DEVICES MARKET – COMPETITIVE LANDSCAPE
8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant
9 PROFILES OF KEY PLAYERS
9.1 Company A
9.1.1 Business Overview
9.1.2 Product Portfolio
9.1.3 Business Strategies
9.1.4 SWOT Analysis
9.1.5 Major News and Events
9.2 Company B
9.2.1 Business Overview
9.2.2 Product Portfolio
9.2.3 Business Strategies
9.2.4 SWOT Analysis
9.2.5 Major News and Events
9.3 Company C
9.3.1 Business Overview
9.3.2 Product Portfolio
9.3.3 Business Strategies
9.3.4 SWOT Analysis
9.3.5 Major News and Events
9.4 Company D
9.4.1 Business Overview
9.4.2 Product Portfolio
9.4.3 Business Strategies
9.4.4 SWOT Analysis
9.4.5 Major News and Events
9.5 Company E
9.5.1 Business Overview
9.5.2 Product Portfolio
9.5.3 Business Strategies
9.5.4 SWOT Analysis
9.5.5 Major News and Events
10 SOUTH KOREA NEUROLOGY DEVICES MARKET - INDUSTRY ANALYSIS
10.1 Drivers, Restraints, and Opportunities
10.1.1 Overview
10.1.2 Drivers
10.1.3 Restraints
10.1.4 Opportunities
10.2 Porters Five Forces Analysis
10.2.1 Overview
10.2.2 Bargaining Power of Buyers
10.2.3 Bargaining Power of Suppliers
10.2.4 Degree of Competition
10.2.5 Threat of New Entrants
10.2.6 Threat of Substitutes
10.3 Value Chain Analysis
11 APPENDIX
